Triovobs 1mg/500mg/0.2mg Tablet SR
Marketer
Ridgecure Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Triovobs 1mg/500mg/0.2mg Tablet SR
Diabetace 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, helping regulate blood glucose. Diabetace 1mg/500mg/0.2mg Extended-Release Tablets should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication is one component of a comprehensive diabetes management plan, which should include a doctor-recommended diet, exercise, and weight management. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms—sweating, dizziness, headache, tremors—and how to manage them. Consistent meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended as directed by your doctor.
Primary Ingredients of Triovobs 1mg/500mg/0.2mg Tablet SR
The provided text is "undefined," which cannot be rephrased while maintaining meaning and intent. There is no text to rewrite.
Uses of Triovobs 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Triovobs 1mg/500mg/0.2mg Tablet SR:
Your physician will determine the correct dosage and treatment length for this medication. Ingest the Triovobs 1mg/500mg/0.2mg Tablet SR whole; do not chew, crush, or divide the tablet. Administer on an empty stomach.
Common Side effects of Triovobs 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Triovobs 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Triovobs 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing. It should be administered on an empty stomach.
How Triovobs 1mg/500mg/0.2mg Tablet SR works:
Extended-release Triovobs tablets (1mg/500mg/0.2mg) contain a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Triovobs 1mg/500mg/0.2mg Tablet SR with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Triovobs 1mg/500mg/0.2mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Triovobs tablets (1mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Employing Triovobs 1mg/500mg/0.2mg Tablet SR is likely inadvisable for individuals with kidney impairment and should be forgone. Medical advice is recommended. Furthermore, its use is discouraged in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Triovobs 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, a low initial dose is usually prescribed; however, the medication is contraindicated in patients with severe liver disease.
What if you forget to take Triovobs 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Triovobs 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triovobs 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently